-
Je něco špatně v tomto záznamu ?
Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats
L. Uttl, E. Szczurowska, K. Hájková, RR. Horsley, K. Štefková, T. Hložek, K. Šíchová, M. Balíková, M. Kuchař, V. Micale, T. Páleníček,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2007
Free Medical Journals
od 2007
Freely Accessible Science Journals
od 2007-11-01
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2007-10-15
Open Access Digital Library
od 2007-01-01
Open Access Digital Library
od 2007-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2007
PubMed
30405327
DOI
10.3389/fnins.2018.00703
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Synthetic cannabinoid compounds are marketed as "legal" marijuana substitutes, even though little is known about their behavioral effects in relation to their pharmacokinetic profiles. Therefore, in the present study we assessed the behavioral effects of systemic treatment with the two synthetic cannabinoids JWH-073 and JWH-210 and the phytocannabinoid Δ9-THC on locomotor activity, anxiety-like phenotype (in the open field) and sensorimotor gating (measured as prepulse inhibition of the acoustic startle response, PPI), in relation to cannabinoid serum levels. Wistar rats were injected subcutaneously (sc.) with JWH-073 (0.1, 0.5, or 5 mg/kg), JWH-210 (0.1, 0.5, or 5 mg/kg), Δ9-THC (1 or 3 mg/kg) or vehicle (oleum helanti) in a volume of 0.5 ml/kg and tested in the open field and PPI. Although JWH-073, JWH-210, Δ9-THC (and its metabolites) were confirmed in serum, effects on sensorimotor gating were absent, and locomotor activity was only partially affected. Δ9-THC (3 mg/kg) elicited an anxiolytic-like effect as suggested by the increased time spent in the center of the open field (p < 0.05). Our results further support the potential anxiolytic-like effect of pharmacological modulation of the endocannabinoid system.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001567
- 003
- CZ-PrNML
- 005
- 20190118115720.0
- 007
- ta
- 008
- 190107s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fnins.2018.00703 $2 doi
- 035 __
- $a (PubMed)30405327
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Uttl, Libor $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia. Department of Physiology, Faculty of Science, Charles University, Prague, Czechia.
- 245 10
- $a Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats / $c L. Uttl, E. Szczurowska, K. Hájková, RR. Horsley, K. Štefková, T. Hložek, K. Šíchová, M. Balíková, M. Kuchař, V. Micale, T. Páleníček,
- 520 9_
- $a Synthetic cannabinoid compounds are marketed as "legal" marijuana substitutes, even though little is known about their behavioral effects in relation to their pharmacokinetic profiles. Therefore, in the present study we assessed the behavioral effects of systemic treatment with the two synthetic cannabinoids JWH-073 and JWH-210 and the phytocannabinoid Δ9-THC on locomotor activity, anxiety-like phenotype (in the open field) and sensorimotor gating (measured as prepulse inhibition of the acoustic startle response, PPI), in relation to cannabinoid serum levels. Wistar rats were injected subcutaneously (sc.) with JWH-073 (0.1, 0.5, or 5 mg/kg), JWH-210 (0.1, 0.5, or 5 mg/kg), Δ9-THC (1 or 3 mg/kg) or vehicle (oleum helanti) in a volume of 0.5 ml/kg and tested in the open field and PPI. Although JWH-073, JWH-210, Δ9-THC (and its metabolites) were confirmed in serum, effects on sensorimotor gating were absent, and locomotor activity was only partially affected. Δ9-THC (3 mg/kg) elicited an anxiolytic-like effect as suggested by the increased time spent in the center of the open field (p < 0.05). Our results further support the potential anxiolytic-like effect of pharmacological modulation of the endocannabinoid system.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Szczurowska, Ewa $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Hájková, Kateřina $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia. Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czechia.
- 700 1_
- $a Horsley, Rachel R $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Štefková, Kristýna $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Hložek, Tomáš $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.
- 700 1_
- $a Šíchová, Klára $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Balíková, Marie $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.
- 700 1_
- $a Kuchař, Martin $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia. Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czechia.
- 700 1_
- $a Micale, Vincenzo $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia. Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
- 700 1_
- $a Páleníček, Tomáš $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czechia. Third Faculty of Medicine, Psychiatric Clinic, Charles University, Prague, Czechia.
- 773 0_
- $w MED00163313 $t Frontiers in neuroscience $x 1662-4548 $g Roč. 12, č. - (2018), s. 703
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30405327 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190118115934 $b ABA008
- 999 __
- $a ind $b bmc $g 1365384 $s 1039690
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 12 $c - $d 703 $e 20181023 $i 1662-4548 $m Frontiers in neuroscience $n Front Neurosci $x MED00163313
- LZP __
- $a Pubmed-20190107